bio børsten IVS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 13.1% 9.3% 13.6% 20.6%  
Credit score (0-100)  0 19 28 18 5  
Credit rating  N/A BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 45 0 0 0  
Gross profit  0.0 16.4 23.4 1.5 0.0  
EBITDA  0.0 16.4 22.6 -19.1 0.0  
EBIT  0.0 16.4 22.6 -19.1 0.0  
Pre-tax profit (PTP)  0.0 16.4 18.7 -19.1 -8.0  
Net earnings  0.0 16.4 13.7 -20.1 -8.0  
Pre-tax profit without non-rec. items  0.0 16.4 22.6 -19.1 -8.0  

 
See the entire income statement

Balance sheet (kDKK) 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 17.4 31.1 15.9 16.5  
Interest-bearing liabilities  0.0 0.0 5.6 0.0 0.0  
Balance sheet total (assets)  0.0 44.9 45.4 28.6 16.5  

Net Debt  0.0 -11.4 -25.5 -15.2 -5.7  
 
See the entire balance sheet

Volume 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 45 0 0 0  
Net sales growth  0.0% 0.0% -100.0% 0.0% 0.0%  
Gross profit  0.0 16.4 23.4 1.5 0.0  
Gross profit growth  0.0% 0.0% 42.7% -93.7% -100.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 45 45 29 16  
Balance sheet change%  0.0% 0.0% 1.1% -36.9% -42.5%  
Added value  0.0 16.4 22.6 -19.1 0.0  
Added value %  0.0% 36.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 -1.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 -1.0 0.0  

Profitability 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
EBITDA %  0.0% 36.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 36.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 96.5% -1,306.9% 0.0%  
Net Earnings %  0.0% 36.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 36.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 36.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 36.5% 50.0% -51.7% 0.0%  
ROI %  0.0% 94.2% 83.5% -72.8% 0.0%  
ROE %  0.0% 94.2% 56.5% -85.7% -49.5%  

Solidity 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Equity ratio %  0.0% 38.7% 68.5% 55.6% 100.0%  
Relative indebtedness %  0.0% 60.5% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 35.5% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -69.6% -112.9% 79.3% 0.0%  
Gearing %  0.0% 0.0% 17.9% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.1% 0.0% 0.0%  

Liquidity 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Quick Ratio  0.0 0.4 2.4 1.4 0.0  
Current Ratio  0.0 1.6 3.2 2.3 0.0  
Cash and cash equivalent  0.0 11.4 31.1 15.2 5.7  

Capital use efficiency 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 345.3 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 98.7% 0.0% 0.0% 0.0%  
Net working capital  0.0 17.4 31.1 15.9 16.5  
Net working capital %  0.0% 38.2% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0